3D Craniofacial Morphologic Development of Healthy Infants

August 6, 2021 updated by: Pangyunchou, Chang Gung Memorial Hospital

Three-dimensional Normative Craniofacial Morphologic Development of Healthy Infants During the First Year of Life

Healthy infants were enrolled to receive three dimensional craniofacial photography regularly at their age of one month, two month, four month, six month, nine month and twelve month. All the image data was analyzed to reveal infants' craniofacial development.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Importance The development of craniofacial morphology in the first year of life is critical, especially when analyzed with longitudinal 3-dimensional photographs.

Objective To evaluate the development of the craniofacial region in healthy infants in the first year of life and provide treatment guidelines for craniofacial deformities such as orofacial clefts and deformational plagiocephaly.

Design, Setting, and Participants Three-dimensional (3D) photographs of included participants were captured using a 3dMD system. Participants were grouped by sex and age (1, 2, 4, 6, 9, and 12 months). We placed 32 craniofacial anatomical landmarks on 3D craniofacial photos. The thin-plate spline algorithm and closest-point matching were applied to transform a symmetric 3D template into a series of scanned images to calculate 3D composite heads at different ages.

Main Outcomes and Measures Average craniofacial meshes were calculated for each group. The growth patterns of the following anthropometric indices were determined: craniofacial height, depth, width, volume, body height, weight, body mass index (BMI), and head circumference.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
30

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taoyuan, Taiwan
        • Chang Gung Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

1 month to 1 year (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Asian ethnicity
  • healthy infants
  • full-term

Exclusion Criteria:

  • growth curve <3%
  • premature
  • congenital craniofacial anomaly
  • hormonal anomaly.
  • chromsomal anomaly
  • thyroid anomaly
  • bone anomaly

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
EXPERIMENTAL: infants longitudinally received three dimensional photo
A series of 3D craniofacial photos were captured using a 3dMDHead System (3dMD, Atlanta, GA, USA) within 7 days before or after the age of 1, 2, 4, 6, 9, and 12 months
Other: three dimensional photography using a 3dMDHead System (3dMD, Atlanta, GA, USA)
A series of 3D craniofacial photos were captured using a 3dMDHead System (3dMD, Atlanta, GA, USA) within 7 days before or after the age of 1, 2, 4, 6, 9, and 12 months.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
craniofacial height
Time Frame: at infants' age of 1 month-old
measurement of craniofacial anthropometry
at infants' age of 1 month-old
craniofacial height
Time Frame: at infants' age of 2 month-old
measurement of craniofacial anthropometry
at infants' age of 2 month-old
craniofacial height
Time Frame: at infants' age of 4 month-old
measurement of craniofacial anthropometry
at infants' age of 4 month-old
craniofacial height
Time Frame: at infants' age of 6 month-old
measurement of craniofacial anthropometry
at infants' age of 6 month-old
craniofacial height
Time Frame: at infants' age of 9 month-old
measurement of craniofacial anthropometry
at infants' age of 9 month-old
craniofacial height
Time Frame: at infants' age of 12 month-old
measurement of craniofacial anthropometry
at infants' age of 12 month-old
craniofacial depth
Time Frame: at infants' age of 1 month-old
measurement of craniofacial anthropometry
at infants' age of 1 month-old
craniofacial depth
Time Frame: at infants' age of 2 month-old
measurement of craniofacial anthropometry
at infants' age of 2 month-old
craniofacial depth
Time Frame: at infants' age of 4 month-old
measurement of craniofacial anthropometry
at infants' age of 4 month-old
craniofacial depth
Time Frame: at infants' age of 6 month-old
measurement of craniofacial anthropometry
at infants' age of 6 month-old
craniofacial depth
Time Frame: at infants' age of 9 month-old
measurement of craniofacial anthropometry
at infants' age of 9 month-old
craniofacial depth
Time Frame: at infants' age of 12 month-old
measurement of craniofacial anthropometry
at infants' age of 12 month-old
craniofacial width
Time Frame: at infants' age of 1 month-old
measurement of craniofacial anthropometry
at infants' age of 1 month-old
craniofacial width
Time Frame: at infants' age of 2 month-old
measurement of craniofacial anthropometry
at infants' age of 2 month-old
craniofacial width
Time Frame: at infants' age of 4 month-old
measurement of craniofacial anthropometry
at infants' age of 4 month-old
craniofacial width
Time Frame: at infants' age of 6 month-old
measurement of craniofacial anthropometry
at infants' age of 6 month-old
craniofacial width
Time Frame: at infants' age of 9 month-old
measurement of craniofacial anthropometry
at infants' age of 9 month-old
craniofacial width
Time Frame: at infants' age of 12 month-old
measurement of craniofacial anthropometry
at infants' age of 12 month-old
craniofacial volume
Time Frame: at infants' age of 1 month-old
measurement of craniofacial anthropometry
at infants' age of 1 month-old
craniofacial volume
Time Frame: at infants' age of 2 month-old
measurement of craniofacial anthropometry
at infants' age of 2 month-old
craniofacial volume
Time Frame: at infants' age of 4 month-old
measurement of craniofacial anthropometry
at infants' age of 4 month-old
craniofacial volume
Time Frame: at infants' age of 6 month-old
measurement of craniofacial anthropometry
at infants' age of 6 month-old
craniofacial volume
Time Frame: at infants' age of 9 month-old
measurement of craniofacial anthropometry
at infants' age of 9 month-old
craniofacial volume
Time Frame: at infants' age of 12 month-old
measurement of craniofacial anthropometry
at infants' age of 12 month-old
body weight
Time Frame: at infants' age of 1 month-old
measurement of craniofacial anthropometry
at infants' age of 1 month-old
body weight
Time Frame: at infants' age of 2 month-old
measurement of craniofacial anthropometry
at infants' age of 2 month-old
body weight
Time Frame: at infants' age of 4 month-old
measurement of craniofacial anthropometry
at infants' age of 4 month-old
body weight
Time Frame: at infants' age of 6 month-old
measurement of craniofacial anthropometry
at infants' age of 6 month-old
body weight
Time Frame: at infants' age of 9 month-old
measurement of craniofacial anthropometry
at infants' age of 9 month-old
body weight
Time Frame: at infants' age of 12 month-old
measurement of craniofacial anthropometry
at infants' age of 12 month-old
body height
Time Frame: at infants' age of 1 month-old
measurement of craniofacial anthropometry
at infants' age of 1 month-old
body height
Time Frame: at infants' age of 2 month-old
measurement of craniofacial anthropometry
at infants' age of 2 month-old
body height
Time Frame: at infants' age of 4 month-old
measurement of craniofacial anthropometry
at infants' age of 4 month-old
body height
Time Frame: at infants' age of 6 month-old
measurement of craniofacial anthropometry
at infants' age of 6 month-old
body height
Time Frame: at infants' age of 9 month-old
measurement of craniofacial anthropometry
at infants' age of 9 month-old
body height
Time Frame: at infants' age of 12 month-old
measurement of craniofacial anthropometry
at infants' age of 12 month-old
body mass index (BMI)
Time Frame: at infants' age of 1 month-old
measurement of craniofacial anthropometry
at infants' age of 1 month-old
body mass index (BMI)
Time Frame: at infants' age of 2 month-old
measurement of craniofacial anthropometry
at infants' age of 2 month-old
body mass index (BMI)
Time Frame: at infants' age of 4 month-old
measurement of craniofacial anthropometry
at infants' age of 4 month-old
body mass index (BMI)
Time Frame: at infants' age of 6 month-old
measurement of craniofacial anthropometry
at infants' age of 6 month-old
body mass index (BMI)
Time Frame: at infants' age of 9 month-old
measurement of craniofacial anthropometry
at infants' age of 9 month-old
body mass index (BMI)
Time Frame: at infants' age of 12 month-old
measurement of craniofacial anthropometry
at infants' age of 12 month-old
head circumference
Time Frame: at infants' age of 1 month-old
measurement of craniofacial anthropometry
at infants' age of 1 month-old
head circumference
Time Frame: at infants' age of 2 month-old
measurement of craniofacial anthropometry
at infants' age of 2 month-old
head circumference
Time Frame: at infants' age of 4 month-old
measurement of craniofacial anthropometry
at infants' age of 4 month-old
head circumference
Time Frame: at infants' age of 6 month-old
measurement of craniofacial anthropometry
at infants' age of 6 month-old
head circumference
Time Frame: at infants' age of 9 month-old
measurement of craniofacial anthropometry
at infants' age of 9 month-old
head circumference
Time Frame: at infants' age of 12 month-old
measurement of craniofacial anthropometry
at infants' age of 12 month-old

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Chang Gung Memorial Hospital

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Pangyun Chou, MD, Chang Gung Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 4, 2018

Primary Completion (ACTUAL)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 27, 2020

Study Completion (ACTUAL)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
November 4, 2020

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 28, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 6, 2021

First Posted (ACTUAL)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 13, 2021

Study Record Updates

Last Update Posted (ACTUAL)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 13, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 6, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 201701939B0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

three dimensional photo acquisition for newborns

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings